These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8778974)
1. Implementation of the rhesus prevention programme: a prospective study. Ghosh S; Murphy WG Scott Med J; 1994 Oct; 39(5):147-9. PubMed ID: 8778974 [TBL] [Abstract][Full Text] [Related]
3. The issue of anti-D: an integrated seamless approach from recognition of need to bedside administration. Ryan MJ; Joyce S; O'Brien N; Lynch E; Burke G; Cahill MR Ir J Med Sci; 2005; 174(3):58-63. PubMed ID: 16285341 [TBL] [Abstract][Full Text] [Related]
4. An audit of the investigation and use of anti-D immunoglobulin prophylaxis in Tayside. Rennie I; Smith A; Smith R; Rawlinson PS; Clark P Health Bull (Edinb); 2001 May; 59(3):150-4. PubMed ID: 12664753 [TBL] [Abstract][Full Text] [Related]
6. Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study. MacKenzie IZ; Bowell P; Gregory H; Pratt G; Guest C; Entwistle CC Br J Obstet Gynaecol; 1999 May; 106(5):492-7. PubMed ID: 10430201 [TBL] [Abstract][Full Text] [Related]
7. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies. Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781 [TBL] [Abstract][Full Text] [Related]
8. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant. Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601 [No Abstract] [Full Text] [Related]
10. Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis. Koelewijn JM; de Haas M; Vrijkotte TG; van der Schoot CE; Bonsel GJ BJOG; 2009 Sep; 116(10):1307-14. PubMed ID: 19538414 [TBL] [Abstract][Full Text] [Related]
11. [Foetal Rhesus-D typing added to antenatal screening for infectious diseases and erythrocyte immunisation]. van der Ploeg CP; Hirschberg HJ; de Haas M; Abbink F Ned Tijdschr Geneeskd; 2015; 159():A8315. PubMed ID: 25898866 [TBL] [Abstract][Full Text] [Related]
12. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region]. Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003 [TBL] [Abstract][Full Text] [Related]
13. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen. Chaffe B; Ford J; Bills V Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141 [TBL] [Abstract][Full Text] [Related]
14. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant]. L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042 [TBL] [Abstract][Full Text] [Related]
15. The use of anti-D immunoglobulins for rhesus prophylaxis: audit on knowledge and practices among obstetricians. Wee WW; Kanagalingam D Singapore Med J; 2009 Nov; 50(11):1054-7. PubMed ID: 19960158 [TBL] [Abstract][Full Text] [Related]
16. Use of anti-D immunoglobulin in the treatment of threatened miscarriage in the accident and emergency department. Weinberg L Emerg Med J; 2001 Nov; 18(6):444-7. PubMed ID: 11696491 [TBL] [Abstract][Full Text] [Related]
17. [Text of the guidelines for prevention of fetomaternal rhesus-D allo-immunization]. College National de Gynecolegues et Obstetriciens Francais J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S131-1S135. PubMed ID: 16495839 [No Abstract] [Full Text] [Related]
18. Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed? Howard HL; Martlew VJ; McFadyen IR; Clarke CA Br J Obstet Gynaecol; 1997 Jan; 104(1):37-41. PubMed ID: 8988694 [TBL] [Abstract][Full Text] [Related]
19. Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years. MacKenzie IZ; Findlay J; Thompson K; Roseman F BJOG; 2006 Jul; 113(7):839-43. PubMed ID: 16827770 [TBL] [Abstract][Full Text] [Related]
20. Time points and risk factors for RhD immunizations after the implementation of targeted routine antenatal anti-D prophylaxis: A retrospective nationwide cohort study. Jernman R; Isaksson C; Haimila K; Kuosmanen M; Mäkikallio-Anttila K; Toivonen S; Ordén MR; Sulin K; Tihtonen K; Vääräsmäki M; Sainio S Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1868-1875. PubMed ID: 34157128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]